LENSAR Profit Margin

The latest profit margin for LNSR is 57.57% as of June 2026. That compares with -84.49% in the prior-year period — up 168.1% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside LENSAR's historical trend and sector peers before judging valuation or financial health.

Over the past year, LNSR's profit margin moved from -84.49% to 57.57% — a 168.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LENSAR's valuation or profitability profile.

Against Healthcare companies, LNSR currently prints 57.57% for profit margin, while the sector average sits near 13.89%. That is roughly 314.4% above the sector mean. Large gaps often invite a closer look at LENSAR's growth, margins, and balance sheet.

Profit Margin shows how effectively LENSAR converts resources into returns. At 57.57%, LNSR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -84.49% in the prior-year period — up 168.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LNSR's profit margin (57.57%), review year-over-year change from -84.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.